ArticleJournal of cancer survivorship : research and practice2026
Infertility costs and associated factors in childhood cancer survivors: the role of radiotherapy.
Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis retrospective cohort study estimated the healthcare expenditure of infertility treatment in women who survived childhood cancer and analyzed associated factors using data from the French Childhood Cancer Survivor Study (FCCSS) cohort. PATIENTS AND
methodsFrom 2578 women in the FCCSS cohort, 118 exposed who received infertility treatment, aged 18-42, were identified based on first recorded drug therapy and/or in vitro fertilization/intracytoplasmic sperm injection and/or medically assisted procreation between 2011 and 2018. Six hundred eight unexposed who had not undergone infertility treatment were selected using propensity score matching. Expenditure related to infertility treatment was estimated as the difference between cases' expenditures and average expenditures of their controls yearly, over a maximum follow-up period of 4 years unexposed.
resultsAverage annual expenditure related to infertility treatment per patient over 4 years was 3043 euros (95% CI: 2240; 3845) (in euros 2025). Expenditure peaked during the first 2 years and among women aged 25-35. Patients treated with radiotherapy alone had higher average annual expenditure of 4531 euros (95% CI: 1781; 7281). In multivariate analysis, radiotherapy alone and chemotherapy alone were associated with increased annual expenditure of 4382 euros (95% CI: 1102.0; 7661.3) and 2018 euros (95% CI: 97.3; 3937.8), respectively, compared to patients without childhood radiotherapy or chemotherapy. Combined radiotherapy and chemotherapy increased infertility-related expenditure (€2132.5 (95% CI: -36.6; 4301.6), p: 0.054) compared with patients who received neither of these two treatments. The magnitude, trends of expenditure, and age at initiation of infertility treatment were consistent with the general population. CONCLUSION IMPLICATIONS FOR CANCER SURVIVORS: The study shows that childhood cancer treatment modalities significantly influence expenditures related to infertility treatment in women, which are implicitly attributable to the adverse effects of these treatments,with radiotherapy being a key driver. These findings support developing public health strategies promoting more targeted paediatric cancer treatments to mitigate long-term costs, particularly those associated with infertility treatment.
Indexed as
Identifiers
42101753What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.